首页 > 市场调查报告书 > 医疗设备

生技设备

HLA 打字全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测

市场调查报告书

商品编码

1267323

HLA 打字全球市场研究报告——2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global HLA Typing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年04月01日 | 出版商:

Value Market Research | 英文 241 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计全球 HLA 分型市场需求将从 2022 年的 510 万美元增长到 2030 年的近 1079 万美元，2023-2030 年研究期间的复合年增长率为 9.82%。 .

HLA 分型是一项实验室测试，用于确定个体的人类白细胞抗原 (HLA) 类型。该测试通常使用少量血液样本进行，需要专门的技术来识别和分析样本中的特定 HLA 蛋白。 HLA 分型通常用于器官移植以确定潜在的供体和受体是否相容。它还用于输血和诊断某些自身免疫性疾病。

市场动态：

HLA 分型的兴起是由于越来越多地使用器官移植作为一种医疗实践。随着器官移植变得越来越普遍和成功，对可靠和准确的 HLA 分型的需求也在增加。此外，HLA 分型在诊断和治疗自身免疫性疾病方面的应用可能会推动市场增长。此外，HLA 分型被用于通过尽可能接近地匹配供体和受体血液来确保输血的安全性和有效性，这可能会促进市场增长。然而，检查过程的成本和復杂性可能会阻碍市场增长。

研究报告描述了波特的五力模型、市场吸引力分析和价值链分析。这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。此外，这些工具还能够全面评估全球 hla 打字市场的每个细分市场。 hla 打字行业的增长和趋势为这项研究提供了一个整体的方法。

市场细分：

本部分提供了按国家和地区划分的细分市场的详细数据，以帮助确定每种产品或服务的目标受众和未来商机。

按产品

仪器
试剂和耗材
软件与服务

按申请

诊断
调查

通过技术

分子检测
基于序列的分子检测
非分子检测

由最终用户

商业服务提供商
医院和移植中心
调查研究机构和学术机构

按地区分析：

本节介绍了区域前景，重点关注北美、欧洲、亚太地区、拉丁美洲、中东和非洲 HLA 分型市场当前和未来的需求。此外，我们还关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 hla 打字市场的主要参与者是 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories Inc.、Qiagen N.V.、Omixon Inc.、GenDx、Illumina Inc.、TBG Diagnostics Limited、Dickinson and Company、Takara Bio Inc.、F. Hoffmann- Laroche 我们是太平洋生物科技有限公司本节包括对竞争格局的全面了解，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

内容

第一章前言

报告内容
- 目的
- 目标受众
- USP（独特的销售建议）及其提供的内容
调查范围
调查方法
- 市场调研流程
- 市场研究方法

第 2 章执行摘要

市场亮点
全球市场概况

第 3 章 HLA 分型 - 行业分析

简介 - 市场动态
市场驱动力
市场製约因素
机会
行业趋势
波特的五力分析
市场吸引力分析
- 按产品分类的市场吸引力分析
- 市场吸引力分析：按应用
- 按技术进行市场吸引力分析
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第四章价值链分析

价值链分析
原材料分析
- 原材料清单
- 原材料製造商列表
- 主要原材料价格走势
潜在买家名单
营销渠道
- 直接营销
- 间接营销
- 市场发展趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章 HLA 分型全球市场分析：按产品类型

产品概览
过去和未来的数据
按产品分析
仪器
试剂和耗材
软件与服务

第 7 章 HLA 分型全球市场分析：按应用

总结：按应用
过去和未来的数据
分析：按应用
诊断
调查

第 8 章 Hla 打字全球市场分析：按技术

技术概述
过去和未来的数据
技术分析
分子检测
基于序列的分子检测
非分子检测

第 9 章 Hla 打字全球市场分析：按最终用户

最终用户总结
过去和未来的数据
最终用户分析
商业服务提供商
医院和移植中心
调查研究机构和学术机构

第 10 章 Hla 打字全球市场分析：按地区

区域展望
介绍
北美销售分析
- 概览、历史和预测销售分析
- 北美各部门的销售分析
- 北美销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史和预测销售分析
- 按细分市场进行的欧洲销售分析
- 按国家/地区划分的欧洲销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 其他欧洲销售分析
亚太地区销售分析
- 概览、历史和预测销售分析
- 亚太地区各部门的销售分析
- 亚太国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本的销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 其他亚太地区销售分析
拉丁美洲销售分析
- 概览、历史和预测销售分析
- 拉丁美洲各部门的销售分析
- 拉丁美洲国家/地区的销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利的销售分析
- 其他拉丁美洲销售分析
中东和非洲销售分析
- 概览、历史和预测销售分析
- 中东和非洲各细分市场的销售额分析
- 中东和非洲国家/地区的销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 其他中东和非洲销售分析

第11章HLA分型公司的竞争格局

草裙舞打字市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他扩展

第12章公司简介

顶级公司份额分析
市场集中度
Thermo Fisher Scientific Inc.
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
Bio-Rad 实验室公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
Qiagen N.V.
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
Omixon 公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
GenDx
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
因美纳公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
TBG 诊断有限公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
狄金森公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
Takara Bio Inc.
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
F. Hoffman-La Roche Limited
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
太平洋生物科学
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

简介目录图表

Product Code: VMR112110056

The global demand for HLA Typing Market is presumed to reach the market size of nearly USD 10.79 MN by 2030 from USD 5.1 MN in 2022 with a CAGR of 9.82% under the study period 2023 - 2030.

HLA typing is a laboratory test that is used to determine an individual's human leukocyte antigen (HLA) type. The test is usually performed using a small blood sample, and it involves the use of specialized techniques to identify and analyze the specific HLA proteins present in the sample. HLA typing is typically used for organ transplantation, as it helps to determine whether a potential donor and recipient are a good match. It is also used in blood transfusions and the diagnosis of certain autoimmune diseases.

Market Dynamics:

The rise of HLA typing has been driven by the increasing use of organ transplantation as a medical treatment. As organ transplantation has become more common and successful, the need for reliable and accurate HLA typing has increased. Moreover, the usefulness of HLA typing in diagnosing and treating autoimmune diseases may drive market growth. Furthermore, HLA typing is used to ensure that blood transfusions are safe and effective by matching the blood of the donor and recipient as closely as possible, which may boost the market's growth. However, the cost and complexity of the testing process may impede market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hla typing. The growth and trends of hla typing industry provide a holistic approach to this study.

Market Segmentation:

This section of the hla typing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Reagents & Consumables
Software & Services

By Application

Diagnosis
Research

By Technique

Molecular Assay
Sequenced-Based Molecular Assay
Non-Molecular Assay

By End-User

Commercial Service Providers
Hospitals And Transplant Centers
Research Labs & Academic Institutes

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the HLA Typing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hla typing market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., TBG Diagnostics Limited, Dickinson and Company, Takara Bio Inc., F. Hoffman-La Roche Limited, Pacific Biosciences. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HLA TYPING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Technique
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HLA TYPING MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Instruments Historic and Forecast Sales by Regions
6.5 Reagents & Consumables Historic and Forecast Sales by Regions
6.6 Software & Services Historic and Forecast Sales by Regions

7 . GLOBAL HLA TYPING MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Diagnosis Historic and Forecast Sales by Regions
7.5 Research Historic and Forecast Sales by Regions

8 . GLOBAL HLA TYPING MARKET ANALYSIS BY TECHNIQUE

8.1 Overview by Technique
8.2 Historical and Forecast Data
8.3 Analysis by Technique
8.4 Molecular Assay Historic and Forecast Sales by Regions
8.5 Sequenced-based Molecular Assay Historic and Forecast Sales by Regions
8.6 Non-Molecular Assay Historic and Forecast Sales by Regions

9 . GLOBAL HLA TYPING MARKET ANALYSIS BY END-USER

9.1 Overview by End-user
9.2 Historical and Forecast Data
9.3 Analysis by End-user
9.4 Commercial Service Providers Historic and Forecast Sales by Regions
9.5 Hospitals And Transplant Centers Historic and Forecast Sales by Regions
9.6 Research Labs & Academic Institutes Historic and Forecast Sales by Regions

10 . GLOBAL HLA TYPING MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE HLA TYPING COMPANIES

11.1. Hla Typing Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF HLA TYPING INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Thermo Fisher Scientific Inc.
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Bio-Rad Laboratories Inc.
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Qiagen N.V.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Omixon Inc.
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. GenDx
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Illumina Inc.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. TBG Diagnostics Limited
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Dickinson and Company
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Takara Bio Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. F. Hoffman-La Roche Limited
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Pacific Biosciences
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表